BUY Amber Enterprises India Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))8 May 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·21 May · today
Pursuant to relevant provision of SEBI (LODR) Regulations, we hereby enclose the Press Release dated 16th May 2026 on the Audited Financial Results (Standalone and Consolidated) of the ....
BSE · Company Update·16 May · 6d ago
The Board of Directors of the Company at its meeting held on 15th May 2026, has approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial ....
BSE · Board Meeting·16 May · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Amber Enterprises India
- SELL — Chandan Taparia, Motilal Oswal9 Oct 2026 · Same day · target ₹6,100 · Expired
- SELL — Laxmikant Shukla, YES Securities15 Sept 2026 · ~2 weeks · target ₹6,700 · Expired
- BUY — Motilal Oswal8 Sept 2026 · ~1 year · target ₹8,250 · Active
- SELL — Somil Mehta, Sharekhan8 Sept 2026 · ~2 weeks · target ₹6,900 · Target hit
- BUY — Siddharth Sedani, Anand Rathi28 Aug 2026 · Same day · target ₹7,900 · Expired
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

